van Lier R - Search Results

1

CD30-antigen-specific targeting and activation of T cells via murine bispecific monoclonal antibodies against CD3 and CD28: potential use for the treatment of Hodgkin's lymphoma.

Pohl C, Denfeld R, Renner C, Jung W, Bohlen H, Sahin U, Hombach A, van Lier R, Schwonzen M, Diehl V, et al. Pohl C, et al. Among authors: van lier r. Int J Cancer. 1993 Jul 9;54(5):820-7. doi: 10.1002/ijc.2910540517. Int J Cancer. 1993. PMID: 7686889

2

The role of lymphocyte subsets and adhesion molecules in T cell-dependent cytotoxicity mediated by CD3 and CD28 bispecific monoclonal antibodies.

Renner C, Jung W, Sahin U, van Lier R, Pfreundschuh M. Renner C, et al. Among authors: van lier r. Eur J Immunol. 1995 Jul;25(7):2027-33. doi: 10.1002/eji.1830250734. Eur J Immunol. 1995. PMID: 7621876

3

Cure of xenografted human tumors by bispecific monoclonal antibodies and human T cells.

Renner C, Jung W, Sahin U, Denfeld R, Pohl C, Trümper L, Hartmann F, Diehl V, van Lier R, Pfreundschuh M. Renner C, et al. Among authors: van lier r. Science. 1994 May 6;264(5160):833-5. doi: 10.1126/science.8171337. Science. 1994. PMID: 8171337

4

Cure of disseminated xenografted human Hodgkin's tumors by bispecific monoclonal antibodies and human T cells: the role of human T-cell subsets in a preclinical model.

Renner C, Bauer S, Sahin U, Jung W, van Lier R, Jacobs G, Held G, Pfreundschuh M. Renner C, et al. Among authors: van lier r. Blood. 1996 Apr 1;87(7):2930-7. Blood. 1996. PMID: 8639913 Free article.

5

Activation and expansion of tumour-infiltrating lymphocytes by anti-CD3 and anti-CD28 monoclonal antibodies.

Nijhuis EW, vd Wiel-van Kemenade E, Figdor CG, van Lier RA. Nijhuis EW, et al. Among authors: van lier ra. Cancer Immunol Immunother. 1990;32(4):245-50. doi: 10.1007/BF01741708. Cancer Immunol Immunother. 1990. PMID: 2175673 Free PMC article.

6

Bispecific antibody-mediated target cell-specific costimulation of resting T cells via CD5 and CD28.

Kroesen BJ, Bakker A, van Lier RA, The HT, de Leij L. Kroesen BJ, et al. Among authors: van lier ra. Cancer Res. 1995 Oct 1;55(19):4409-15. Cancer Res. 1995. PMID: 7545540

7

Efficient expansion of tumor-infiltrating lymphocytes from solid tumors by stimulation with combined CD3 and CD28 monoclonal antibodies.

Flens MJ, Mulder WM, Bril H, von Blomberg van de Flier MB, Scheper RJ, van Lier RA. Flens MJ, et al. Among authors: van lier ra. Cancer Immunol Immunother. 1993 Oct;37(5):323-8. doi: 10.1007/BF01518455. Cancer Immunol Immunother. 1993. PMID: 8402736 Free PMC article.

8

Defect of interleukin-2 production and T cell proliferation in atopic patients: restoring ability of the CD28-mediated activation pathway.

Romano MF, Turco MC, Stanziola A, Giarrusso PC, Petrella A, Tassone P, van Lier R, Venuta S, Formisano S. Romano MF, et al. Among authors: van lier r. Cell Immunol. 1993 May;148(2):455-63. doi: 10.1006/cimm.1993.1127. Cell Immunol. 1993. PMID: 8098674

9

T cell receptor/CD3 and CD28 use distinct intracellular signaling pathways.

Van Lier RA, Brouwer M, De Groot ED, Kramer I, Aarden LA, Verhoeven AJ. Van Lier RA, et al. Eur J Immunol. 1991 Jul;21(7):1775-8. doi: 10.1002/eji.1830210731. Eur J Immunol. 1991. PMID: 1647959

10

Signals involved in T cell activation. T cell proliferation induced through the synergistic action of anti-CD28 and anti-CD2 monoclonal antibodies.

Van Lier RA, Brouwer M, Aarden LA. Van Lier RA, et al. Eur J Immunol. 1988 Jan;18(1):167-72. doi: 10.1002/eji.1830180125. Eur J Immunol. 1988. PMID: 3126073

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

454 results

Search Page

Filters